Vijaya Diagnostic Centre Limited
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.
What Vijaya files
- Others81
- Investor Meet39
- Important16
- Board Meeting13
- Updates11
- PPTs7
Vijaya Diagnostic Centre reported strong quarterly results: Revenue up 22.8% YoY to ₹230.98 Cr, EBITDA up 34.0% to ₹98.54 Cr, PAT up 37.6% to ₹53.10 Cr. Volume grew 16.5%. Company expanded its network with new hubs in Hyderabad & Bengaluru, and 4 spokes, boosting reach.
Vijaya Diagnostic reports strong Q4 FY26 revenue of ₹219.38 Cr (+26.6% YoY) & PAT of ₹47.93 Cr (+37.5% YoY). FY26 revenue crossed ₹814 Cr. Plans include 4-5 new hubs, 10-12 spokes, an automated lab, and genomic testing, indicating continued expansion.
Board approved Q4/FY financial results. A ₹2/share dividend was proposed. Granted 1.79 lakh ESOPs at ₹784/option. Acquired MRI, EEG, NCV services from its wholly-owned subsidiary for ~₹4.20 Cr, integrating operations. An Independent Director will not seek re-appointment.
Vijaya Diagnostic reports strong Q3 revenue of ₹205.21 Cr (+21.4% YoY) and PAT of ₹43.18 Cr (+22.3% YoY). Nine-month revenue reached ₹594.83 Cr. The company expanded its network with new hubs in West Bengal and core markets, with some achieving early break-even.
Vijaya Diagnostic reports Q2FY26 revenue of 201.56 Cr (+10.2% YoY) and PAT of 43.28 Cr (+2.7%). H1 revenue grew 14.9%, driven by volume. Medinova merger finalized. Operational momentum includes new Kolkata hub, early Bengaluru hub break-even, and plans for a flagship Bengaluru centre.